Prolia® (denosumab) is used to treat osteoporosis in women after the menopause and in men, and has been shown to reduce the risk of spinal, non-spinal and hip fractures. Prolia® mimics a protein found in your body that blocks the process causing bone loss, helping to make your bones stronger and less likely to break.1Your doctor will have considered your medical history and circumstances, as well as information available before deciding to prescribe Prolia®. This might have included clinical trials demonstrating:1
The ability of Prolia® to reduce bone loss and gradually restore bone mass
The ability of Prolia® to reduce the risk of fracture
The side effect profile of Prolia®
Prolia® (denosumab) Summary of Product Characteristics.